Cellerant Therapeutics logo

Cellerant Therapeutics

A biotechnology company that develops treatments for cancer and hematologic conditions

2

Funding Rounds

$18.1m

Money raised

Overview

A biotechnology company that develops treatments for cancer and hematologic conditions

Funding

Funding series

Funding Series Analysis

The company Cellerant Therapeutics has raised a total of $18.09m in funding over 2 rounds.

Key Insights:

  • Cellerant Therapeutics funding round, September 2012: $2.09m
  • Cellerant Therapeutics Series B round: $16m
Cellerant Therapeutics logo
Cellerant Therapeutics funding round, September 2012 $2.09m
Cellerant Therapeutics logo
Cellerant Therapeutics Series B round $16m